AprilBio Co.,Ltd. (KOSDAQ:397030)
South Korea · Delayed Price · Currency is KRW 25,050
+250 (1.01%)
At close: Jul 27, 2026
AprilBio Market Cap
AprilBio has a market cap or net worth of 535.01 billion as of July 28, 2026. Its market cap has increased by 5.55% in one year.
Market Cap
535.01B
Enterprise Value
452.50B
Revenue
725.35M
Ranking
n/a
PE Ratio
n/a
Stock Price
25,050.00
ChartMarket Cap Chart
Since July 28, 2022, AprilBio's market cap has increased from 229.75B to 535.01B, an increase of 132.87%. That is a compound annual growth rate of 23.53%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 27, 2026 | 586.52B | -53.97% |
| Dec 30, 2025 | 1.27T | 250.56% |
| Dec 30, 2024 | 363.46B | -0.02% |
| Dec 28, 2023 | 363.53B | 96.13% |
| Dec 29, 2022 | 185.35B | -19.33% |
| Jul 28, 2022 | 229.75B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aimed Bio | 1.36T |
| JS Link | 1.14T |
| Rznomics | 744.07B |
| Qurient | 723.42B |
| ROKIT Healthcare | 698.05B |
| Inventage Lab | 391.02B |
| Curocell | 358.57B |
| IntoCell | 296.68B |